Combining Apatinib and Oxaliplatin Remodels the Immunosuppressive Tumor Microenvironment and Sensitizes Desert-Type Gastric Cancer to Immunotherapy

Journal:
Cancer Research
Published:
DOI:
10.1158/0008-5472.can-24-2697
Affiliations:
5
Authors:
15
Go to article
Institutions Authors Share
Fujian Medical University, China
8.666667
 0.58
Fujian Medical University Union Hospital, China
5.333333
 0.36
The University of Tokyo (UTokyo), Japan
1.000000
 0.07
Interested in Oncology and Carcinogenesis?